Literature DB >> 11530174

Estimated risk of HIV transmission by blood transfusion in Kenya.

A Moore1, G Herrera, J Nyamongo, E Lackritz, T Granade, B Nahlen, A Oloo, G Opondo, R Muga, R Janssen.   

Abstract

BACKGROUND: During the past decade, developing countries have received limited support for blood safety programmes. The Kenya Ministry of Health did a collaborative multicentre assessment to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in this country with a mature HIV epidemic, and to identify methods to reduce the risk of HIV transmission by blood transfusion in Kenya.
METHODS: For 12 weeks, from April to July 1994, we collected information and blood samples from all blood donors, and pretransfusion samples were collected from all recipients in six government hospitals in Kenya. Blood donations were collected and screened for HIV according to standard practice in the hospital laboratories. Test results at a reference laboratory were compared with those of the hospital laboratories and risk of transfusion-associated HIV transmission was calculated.
FINDINGS: The prevalence of HIV among blood donors was 6.4% (120 of 1877) and varied by hospital (range 2-20%). HIV test results were available for 1290 donor-recipient pairs. Of these, 26 HIV-positive donations were given to HIV-negative patients. We estimate that 2.0% of transfusions transmitted HIV. Problems in the hospitals that contributed to transfusion risk included inconsistent refrigeration, data entry errors, equipment failure, and lack of a quality-assurance programme.
INTERPRETATION: A high proportion of blood transfusions transmitted HIV in this high-prevalence area of Africa, primarily because of erroneous laboratory practices. On the basis of these results, the Kenya Ministry of Health introduced a number of practical and inexpensive interventions to improve national blood safety.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530174     DOI: 10.1016/S0140-6736(01)05783-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples.

Authors:  Lena Novack; Noya Galai; Arieh Yaari; Mordechai Orgel; Eilat Shinar; Batia Sarov
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country.

Authors:  J P Pitman; R Wilkinson; S V Basavaraju; B von Finckenstein; C Smit Sibinga; A A Marfin; M J Postma; M Mataranyika; J Tobias; D W Lowrance
Journal:  ISBT Sci Ser       Date:  2014-12-01

3.  Estimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia.

Authors:  Benjamin P L Meza; Britta Lohrke; Robert Wilkinson; John P Pitman; Ray W Shiraishi; Naomi Bock; David W Lowrance; Matthew J Kuehnert; Mary Mataranyika; Sridhar V Basavaraju
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

Review 4.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

5.  Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia.

Authors:  Rolf Fendel; Christian Brandts; Annika Rudat; Andrea Kreidenweiss; Claudia Steur; Iris Appelmann; Bettina Ruehe; Paul Schröder; Wolfgang E Berdel; Peter G Kremsner; Benjamin Mordmüller
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

6.  Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters.

Authors:  Gadi Borkow; Humberto H Lara; Chandice Y Covington; Adeline Nyamathi; Jeffrey Gabbay
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

7.  High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China.

Authors:  Nana Wu; Qinjuan Ge; Qingchuan Feng; Jun Zhang; Xiaoxia Liu; Caihong Sun; Yongkang Xu; Guangli He; Chiyu Zhang
Journal:  Indian J Virol       Date:  2011-06-30

8.  Prevalence and risk factors for hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in transfused children in Kinshasa.

Authors:  M Katabuka; M E Mafuta; A M Ngoma; P Mutombo Beya; S Yuma; L Aketi; K P Kayembe; J R Gini
Journal:  Indian J Pediatr       Date:  2012-11-24       Impact factor: 1.967

9.  Quality of paediatric blood transfusions in two district hospitals in Tanzania: a cross-sectional hospital based study.

Authors:  Dominic Mosha; Anja Poulsen; Hugh Reyburn; Elimsaada Kituma; Frank Mtei; Ib C Bygbjerg
Journal:  BMC Pediatr       Date:  2009-08-14       Impact factor: 2.125

10.  Quantifying HIV-1 transmission due to contaminated injections.

Authors:  Richard G White; S Cooper Ben; Anusha Kedhar; Kate K Orroth; Sam Biraro; Rebecca F Baggaley; Jimmy Whitworth; Eline L Korenromp; Azra Ghani; Marie-Claude Boily; Richard J Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.